ClinicalTrials.Veeva

Menu

Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD

A

Ain Shams University

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Menorrhagia

Treatments

Drug: Tranexamic Acid
Drug: Diosmin

Study type

Interventional

Funder types

Other

Identifiers

NCT02616731
TXAvsDiosmin-IUDmenorrhagia

Details and patient eligibility

About

To compare the efficacy of tranexamic acid and diosmin in reducing menstrual blood loss in women having Intra Uterine Contraceptive Device (IUD) and suffer from menorrhagia.

Enrollment

100 estimated patients

Sex

Female

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women complaining from an menorrhagia secondary to a current copper IUD use.
  • Age: 20-40years.
  • Menorrhagia , will be defined as a PBAC-Score greater than 100.
  • No systemic causes of abnormal uterine bleeding as hypertension and hemorrhagic blood diseases.
  • No other local causes of abnormal uterine bleeding as, (fibroid, adenomyosis, polyps).
  • No drugs decreasing blood coagulation.
  • Well fitted IUD not misplaced.

Exclusion criteria

  • Age <20y and >40y.
  • Irregular menstrual cycle.
  • Presence of systemic causes of abnormal uterine bleeding as hypertension and hemorrhagic blood diseases.
  • Presence of other local causes of abnormal uterine bleeding as, (fibroid, adenomyosis, polyps).
  • Taking drugs decrease blood coagulation.
  • Misplaced IUD.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Tranexamic acid
Active Comparator group
Treatment:
Drug: Tranexamic Acid
Diosmin
Active Comparator group
Treatment:
Drug: Diosmin

Trial contacts and locations

1

Loading...

Central trial contact

ahmed alanwar, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems